KP TISSUE INC (KPTSF:OTCMKTS)
$8.83 0.16 (1.8454%)
Analysed KP TISSUE INC (KPTSF:OTCMKTS) News Sources
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
18-02-2026
yahoo.com
KP Tissue Inc (KPTSF) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Profitability ...
18-02-2026
yahoo.com
KP Tissue Q4 Earnings Call Highlights
19-02-2026
marketbeat.com
KP Tissue to Release its Financial Results and Those of Kruger Products Inc. For the First Quarter of 2026
14-04-2026
yahoo.com
RETRANSMISSION: KP Tissue to Release its Financial Results and Those of Kruger Products Inc. for the First Quarter of 2026
13-05-2026
yahoo.com
KP Tissue Releases First Quarter 2026 Financial Results
14-05-2026
yahoo.com
KP Tissue Increases Quarterly Dividend to $0.21 per Common Share Due to the Change in Tax Designation
14-05-2026
yahoo.com
KP Tissue Inc (KPTSF) Q1 2026 Earnings Call Highlights: Strong EBITDA Growth Amid Revenue Challenges
14-05-2026
yahoo.com
KP Tissue Q1 Earnings Call Highlights
16-05-2026
marketbeat.com
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with Its 2026 Annual Meeting of Shareholders
21-05-2026
yahoo.com
What is the current price of KP TISSUE INC (KPTSF:OTCMKTS)?
The current price of KP TISSUE INC (KPTSF:OTCMKTS) is $8.83.
KP TISSUE INC (KPTSF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of KP TISSUE INC (KPTSF:OTCMKTS) since the previous trading day is $0.16.
KP TISSUE INC (KPTSF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of KP TISSUE INC (KPTSF:OTCMKTS) since the previous trading day is 1.8454%.
What is the most recent average sentiment score for KP TISSUE INC (KPTSF:OTCMKTS)?
The most recent average sentiment score for KP TISSUE INC (KPTSF:OTCMKTS) is 61 out of 100.
What is the most recent average sentiment for KP TISSUE INC (KPTSF:OTCMKTS)?
The most recent sentiment for KP TISSUE INC (KPTSF:OTCMKTS) is .
SEC-8K** Filing Available For KP TISSUE INC (KPTSF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.